Tag: Dana-Farber Cancer Institute
-
Nation & World
Treatment resistance in some cancer cells may be reversible
The ability of cancer cells to resist treatment with either targeted drug therapies or traditional chemotherapy may, in some cases, result from a transient state of reversible drug “tolerance.” In…
-
Nation & World
New cancer drug screening method created
Scientists affiliated with Harvard Medical School say they’ve developed a laboratory technique that improves on traditional methods of screening potential anti-cancer drugs.
-
Nation & World
Dana-Farber calls for artists
The Dana-Farber Cancer Institute is looking for artists to help create its 2010 collection of holiday cards and candle wraps.
-
Nation & World
Another piece of cancer puzzle falls into place
An international team of researchers has created a genome-scale map of 26 cancers, revealing more than 100 genomic sites where DNA from tumors is either missing or abnormally duplicated compared to normal tissues.…
-
Nation & World
Genes linked to breast cancer drug resistance
Harvard researchers at the Dana-Farber Cancer Institute have discovered a “gene activity signature” that predicts a high risk of cancer recurrence in some breast tumors that have been treated with…
-
Nation & World
Cancer vaccine success
A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week (Nov. 25) in the journal Science Translational Medicine.
-
Nation & World
First cancer vaccine to eliminate tumors in mice
A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, a team of Harvard bioengineers and biologists report…
-
Nation & World
Researchers ‘NOTCH’ a victory in war on cancer
Normal 0 0 1 819 4673 38 9 5738 11.1282 0 0 0 Scientists have devised an innovative way to disarm a key protein considered to be “undruggable,” meaning that…
-
Nation & World
Breast cancer: Scourge of developing world
Three-day symposium opens, focusing attention on the rise of breast cancer in developing nations, even as resources are scarce to contain it.
-
Nation & World
Darkness with the light
Adult survivors of childhood cancer have an increased risk of suicidal thoughts, even decades after their cancer treatments have ended, according to a study led by Harvard researchers at Dana-Farber…
-
Nation & World
Three Harvard teams to receive $9 million each in federal funding for stem cell research
Three teams of Harvard Stem Cell Institute (HSCI) researchers are slated to receive $27 million over seven years in National Heart Lung and Blood Institute (NHLBI) grants for the development…
-
Nation & World
Donations to cancer institute hit $1b
A Dana-Farber Cancer Institute fund-raising campaign has hit the $1 billion mark a year earlier than expected – despite the ragged economy – setting what is believed to be a record for New England health care institutions. The drive’s success, which will be announced today, appears to have few national parallels, although at least one…
-
Nation & World
What the end-of-life conversation can bring
Professor Holly Prigerson, director of the Center for Psycho-oncology and Palliative Care Research at the Dana Farber Cancer Institute, has confronted the issue professionally and personally. Last fall Prigerson and her co-investigators published a study in The Journal of the American Medical Association examining how end-of-life care discussions between doctors and terminal patients affected the…
-
Nation & World
Study finds promise in combined transplant/vaccine therapy for high-risk leukemia
Two of the most powerful approaches to cancer treatment — a stem cell transplant and an immune system-stimulating vaccine — appear to reinforce each other in patients with an aggressive,…
-
Nation & World
Study supports DNA repair-blocker research in cancer therapy
Scientists at Dana-Farber Cancer Institute have uncovered the mechanism behind a promising new approach to cancer treatment: damaging cancer cells’ DNA with potent drugs while simultaneously preventing the cells from…
-
Nation & World
Postdiagnosis aspirin use reduces risk of dying from colorectal cancer
Regular use of aspirin after colorectal cancer diagnosis may reduce the risk of cancer death, report Harvard researchers at Massachusetts General Hospital (MGH), Dana-Farber Cancer Institute (DFCI) and Brigham and Women’s Hospital. In today’s edition of the Journal of the American Medical Association, the study’s authors also find that the aspirin-associated survival advantage was seen…
-
Nation & World
Scientists create energy-burning brown fat in mice
Harvard researchers at Dana-Farber Cancer Institute have shown that they can engineer mouse and human cells to produce brown fat, a natural energy-burning type of fat that counteracts obesity. If…
-
Nation & World
An unusual collection: A brain tumor tissue bank
Five years ago, as she was walking into Caritas Holy Family Hospital and Medical Center in Methuen, Mass., Patricia Fay saw a priest she knew and cornered him. “I’m like…
-
Nation & World
First molecular steps to childhood leukemia identified
A Harvard research based at Massachusetts General Hospital has identified how a chromosomal abnormality known to be associated with acute lymphoblastic leukemia (ALL) – the most common cancer in children…
-
Nation & World
Study pinpoints novel cancer gene and biomarker
Dana-Farber Cancer Institute scientists’ discovery of a cancer-causing gene – the first in its family to be linked to cancer – demonstrates how the panoramic view of genomics and the…
-
Nation & World
After a century, link between chromosomal instability and centrosome defects in cancer cells is unraveled
In a new study, Dana-Farber Cancer Institute scientists disprove a century-old theory about why cancer cells often have too many or too few chromosomes, and show that the actual reason…
-
Nation & World
AML patients benefit from stem cell transplants
A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute…
-
Nation & World
DFCI cancer research highlights age-related treatment effectiveness, patient cost concerns
New research from the Dana-Farber Cancer Institute highlights age-related responses to colon cancer treatment and patient attitudes toward cost of drugs to manage side effects. Research presented at the American…
-
Nation & World
Genetic testing for breast or ovarian cancer risk may be greatly underutilized
Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds…
-
Nation & World
Scientists create custom three-dimensional structures with ‘DNA origami’
By combining the art of origami with nanotechnology, Dana-Farber Cancer Institute researchers have folded sheets of DNA into multilayered objects with dimensions thousands of times smaller than the thickness of…
-
Nation & World
MicroRNA discovered to play role in DNA repair
Among their many roles as message couriers and gene regulators, microRNA molecules also help control the repair of damaged DNA within cells, Dana-Farber Cancer Institute and Harvard Medical School scientists…
-
Nation & World
Breast cancer danger rising in developing world
Women in developing nations, once thought to have a small chance of contracting breast cancer, are increasingly getting the disease as lifestyles incorporate risk factors common in industrialized nations, panelists at the Harvard School of Public Health (HSPH) said Tuesday (April 14).
-
Nation & World
Link found between religious belief, intensive medical care at end of life
In a new study of terminally ill cancer patients, researchers at Dana-Farber Cancer Institute found that those who draw on religion to cope with their illness are more likely to…
-
Nation & World
Blood type study sheds light on biology of pancreatic cancer
Offering a novel clue about the basic biology of pancreatic cancer, researchers at Dana-Farber Cancer Institute have confirmed a decades-old discovery of a link between blood type and the risk…